Share on LinkedIn Share on Twitter Share on Facebook How We Helped an Innovative Biotech Company Drive SEC Filing Efficiencies. Share on LinkedIn Share on Twitter Share on Facebook Discover how DFIN helped Virax Biolabs, a newly public biotech company focused on the detection of immune responses to viral diseases, streamline their SEC filing process and boost productivity with ActiveDisclosure. To learn more, download the case study below. Case study How We Helped an Innovative Biotech Company Drive SEC Filing Efficiencies. Download Related Products and Solutions Knowledge Hub Page (Insight) ActiveDisclosure℠ Collaborate easily. Simplify reporting. Learn More Related Content Video Podcast Streamlining & Optimizing Financial Reporting with Jeff Catt, DFIN’s Senior Vice President of Global Sales, ActiveDisclosure